Portal Vein Resection and Reconstruction



Portal Vein Resection and Reconstruction


Steven J. Hughes

Kevin E. Behrns





PATIENT HISTORY AND PHYSICAL FINDINGS



  • Most borderline resectable patients will ultimately be staged with N1 disease.4 Thus, these patients have a 5-year survival that is very close to the operative mortality.


  • Previous central venous access or venothromboembolic events may be a contraindication to venous reconstruction because of venous hypertension.


  • A history of hypercoagulability must be considered as an additional risk and factored into consideration for surgical therapy and potential for postoperative anticoagulation.


  • Lower extremity edema is a contraindication for use of the deep femoral vein as conduit.


IMAGING AND OTHER DIAGNOSTIC STUDIES



  • A high-quality, multidetector, thin-slice, triphasic computed tomography (CT) scan is essential (FIG 1). Pay particular attention to the PV phase; loss of the fat plane for greater than 180 degrees or narrowing of the mesentericoportal complex are predictive of PV involvement by neoplasm.5


  • Obtain bilateral duplex ultrasound studies of the deep femoral and jugular veins. Surface mapping of deep femoral vein assists in harvesting the conduit but is not required for success.






FIG 1A. CT of a patient with pancreatic cancer demonstrating SMV involvement. B. The insertion of the first jejunal branch proved to be involved. The resulting lateral wall defect was repaired with a bovine pericardial patch. C. CT of a patient with large pancreatic cancer demonstrating 180-degree effacement of the SMV and (D) middle colic vein involvement. An interposition graft was planned and ultimately required to obtain an R0 resection and perform the subsequent reconstruction.



PREOPERATIVE PLANNING



  • Key to success is the accurate, preoperative determination that an interposition graft will be required.


  • If the vein is narrowed, plan for a circumferential excision with primary repair versus interposition graft. Using the CT scan, estimate the length of the PV involved and the resulting defect requiring reconstruction (FIG 2).



    • A defect measuring less than 2 cm can usually be repaired primarily.


    • A defect 2 to 4 cm typically can be reconstructed using an interposition graft.


    • Defects measuring more than 4 cm will result in a longsegment conduit; the risk of graft thrombosis is proportional to the length, and longer segment reconstructions may preclude surgical therapy.






      FIG 2 • Potential resection options and the associated reconstruction approaches in ascending level of complexity. A. A common location for a lesion that involves the lateral aspect of the PV but where the medial wall (involving the SV/PV confluence) can be preserved. The red line indicates the planned vein resection margin. B. Transverse closure of a longitudinal lateral wall defect. C. Use of a patch to repair a large lateral wall defect. (continued)







      FIG 2(Continued) D. A lesion resulting in significant narrowing of the SMV requiring excision of the vein. The red areas represent the planned resection margin. E. Primary end-to-end venous anastomosis for reconstruction. This approach is appropriate when the vein defect is less than a 2-cm gap or with mesenteric mobilization; the ends can be approximated without tension. F. Reconstruction using an autologous vein graft (gap in excess of 2 cm or under tension). G. If the SV confluence with the SMV is involved, reconstruction of SV inflow is optional.


  • Tumor involvement with respect to the splenic vein (SV) and superior mesenteric vein (SMV) confluence must be considered.



    • If the lateral wall is involved, a primary transverse repair or patch repair is ideal.


    • If a circumferential vein resection is required and a primary end-to-end anastomosis or interposition graft planned, most experienced surgeons do not reinsert the SV—this significantly increases the complexity of the procedure. Rather, the SV is ligated proximally. The risk of sinister portal hypertension leading to symptoms is acceptably low.


  • Consider initiating or continuing a daily enteric-coated aspirin (81 mg) through the perioperative period.


  • Have a bovine pericardium patch available.


  • Most centers have abandoned the use of cadaveric vein grafts.


  • Strongly consider a neoadjuvant approach for all patients with borderline resectable disease. An R1 resection confers no survival benefit over a nonsurgical, palliative therapeutic approach.


  • Neoadjuvant therapy should be offered to all patients in whom there is a loss of the fat plane around the superior mesenteric artery (SMA).